Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

- 13/01/21 - 13 Formulaires, 1 Groupe Item, 88 Eléments de données, 1 Langue
Groupe Item: Anamnese/Risikofaktoren
This version of the GECCO logical model is based on on the "final" version published mid to end September 2020. For actual use of FHIR profiles, please use the profiles available on (FHIR download on MDM is only a FHIR questionnaire profile). A few items implicated by comments/descriptions of items on art-decor have been added: "Datum der letzten Impfung" (date of last vaccination for all listed vaccinations), "Schweregrad" (Severity of Kidney Diseases), "Ort" (Location of vacation in the last 14 days), "Befund bildgebender Verfahren im Rahmen von COVID-19" added separately for all types of imaging procedures listed, "Symptom Schweregrad" (Severity of Symptoms) for each symptom listed, and an "NCT-/EudraCT-Nummer" item for Study participation. Official German text from Zur Bewältigung der aktuellen Pandemie und der damit einhergehenden Behandlung von Patienten fördert das Bundesministerium für Bildung und Forschung (BMBF) ein nationales Netzwerk der Universitätsmedizin im Kampf gegen COVID-19. Unter anderem soll das Netzwerk die Daten der behandelten COVID-19 Patienten systematisch erfassen und bündeln. Die Forschenden sollen die Behandlung der COVID-19-Patienten standardisiert erheben, verfolgen und analysieren. Die hohe Bedrohungslage hat zu intensiver wissenschaftlicher Aktivität zu COVID-19 geführt, wozu zahlreiche regionale, nationale und internationale epidemiologische Erhebungen und Registerstudien zählen. Der Konsensusdatensatz gibt der Wissenschaft um COVID-19 eine gemeinsame Sprache und Arbeitsgrundlage. Inofficial translation: In order to cope with the current pandemic and the associated treatment of patients, the Federal Ministry of Education and Research (BMBF) is funding a national network of university medicine in the fight against COVID-19. Among other things, the network will systematically collect and bundle the data of the treated COVID-19 patients. The researchers are to collect, track and analyze the treatment of COVID-19 patients in a standardized way. The high threat level has led to intensive scientific activity on COVID-19, including numerous regional, national and international epidemiological surveys and register studies. The consensus data set provides a common language and working basis for the science around COVID-19. Not yet integrated: Items for "Data Absent Reason", "Certainty of Presence", "Uncertainty of Presence", and "Certainty of absence"; "therapeutic intention", "Medication Statement Status", "EventStatus"; longer versions of the ValueSets published separately from the variables in art-decor.


1 Groupe Item, 11 Eléments de données


1 Groupe Item, 11 Eléments de données


1 Groupe Item, 22 Eléments de données


1 Groupe Item, 3 Eléments de données
- 20/07/19 - 1 Formulaire, 6 Groupes Item, 55 Eléments de données, 1 Langue
Groupes Item: Case data, Medical Department data, Diagnosis details, Procedure Details, PIA-Documentation of services, Modell project
- 21/04/18 - 1 Formulaire, 14 Groupes Item, 133 Eléments de données, 1 Langue
Groupes Item: Adverse Events, Concomitant Medication, Demographics, Disease Characteristics, Disposition, ECG, Laboratory, Laboratory Data, Medical History, Patient Reported Outcome, Substance Use, Surgery, Tumor Response, Vital Signs
- 30/04/20 - 1 Formulaire, 8 Groupes Item, 46 Eléments de données, 1 Langue
Groupes Item: Administrative Data, Demographic factors, Baseline health status, Prior Treatments, TREATMENT VARIABLES, Acute complications of treatment, Major surgery complications, Major interventional cardiology complications
CORONARY ARTERY DISEASE DATA COLLECTION Version 2.0.3 Revised: April 5th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement ( The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: Asymptomatic Coronary Artery Disease | Stable Angina | Acute Coronary Syndrome (Includes AMI) Treatment Approaches: Lifestyle Modification | Drug Therapy | Percutaneous Coronary Intervention (PCI) | Coronary Artery Bypass Grafting (CABG) This form contains peri-interventional clinical items. The items cover a timespan from prior to the intervention (e.g. PCI or CABG) until 30 days after it. They should be assessed at the entry event and at any new index event (e.g. new revascularization procedure or new diagnosis of ACS). Questionnaires used in this standard set: Rose Dyspnea Scale: The Rose Dyspnea Scale is free for all health care organizations, and a license is not needed. More information may be found at Patient Health Questionnaire (PHQ-2): The PHQ-2 is free for all health care organizations, and a license is not needed. Copyright Pfizer, more Information on Seattle Angina Questionnaire (SAQ-7): Due to the need for a license for use of the SAQ-7 the actual questions of SAQ-7 will not be part of this version of the standard set. Publication: McNamara RL, Spatz ES, Kelley TA, et al. Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc. 2015;4(5):e001767. Published 2015 May 19. doi:10.1161/JAHA.115.001767 For this version of the standard set, semantic annotation with UMLS CUIs has been added.